Number of the records: 1
adalimumab
SYS d000068879 LBL 00000cx^^^2200181-^^45^^ 005 20240119201227.0 100 $a 20160101asloy0103 ba0 152 $b mesh 250 $a adalimumab $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 2016 (2002) $8 eng 330 1-
$a A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS. $8 eng 450 $a protilátka D2E7 $5 e $8 slo 450 $a adalimumab-adbm $5 e $8 slo 450 $a adalimumab-atto $5 e $8 slo 450 $a Amjevita $5 e $8 slo 450 $a Cyltezo $5 e $8 slo 450 $a Humira $5 e $8 slo 550 $3 sllk_un_auth*d014409 $Y Tumor Necrosis Factor-alpha $5 F $a faktor nekrotizujúci nádory, alfa 550 $3 sllk_un_auth*d014409 $Y Tumor Necrosis Factor-alpha $5 B $a faktor nekrotizujúci nádory, alfa 686 $a D12.776.124.486.485.114.224.060.250 686 $a D12.776.124.790.651.114.224.060.250 686 $a D12.776.377.715.548.114.224.200.250 750 $a Adalimumab $8 eng 801 -0
$a SK $b BA006 $c 20160207 801 -2
$a SK $b BA006 $c 20160209 801 -2
$a SK $b BA006 $c 20210118 980 $x M
Number of the records: 1